Amendment ID: S2651-7

Amendment 7

Ensuring epinephrine injector access for minors

Ms. DiZoglio, Messrs. Collins, Tarr, Pacheco and O'Connor move that the proposed new draft be amended by inserting after section 68 the following section:-

SECTION XX. For purposes of this section, the term “epinephrine injector” shall include an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector.

Notwithstanding any general or special law to the contrary, the center for health information and analysis shall provide a cost estimate review and evaluation of coverage for medically necessary appropriate weight-based dosage epinephrine injectors for persons 18 years of age or under; provided, however, that coverage shall not be subject to any deductible, co-insurance or co-pay; provided further, that the review and evaluation shall include an estimate of costs to the commonwealth under 45 C.F.R. 155.170.

Not later than June 30, 2022, the review and evaluation shall be posted on the center’s website and shall be filed with the clerks of the senate and the house of representatives and the house and senate committees on ways and means.